Ole Dahlberg
Directeur/Membre du Conseil chez MEDISTIM ASA
Profil
Ole Jesper Dahlberg is the founder of Cytomics Pharmaceuticals SA, which was founded in 2000.
Mr. Dahlberg is also the founder of Qvint Biotech AS.
Mr. Dahlberg's current job is Chief Executive Officer at Curida Holding AS.
Mr. Dahlberg is also the Chairman of Nadeno Nanoscience AS starting in 2023.
Additionally, Mr. Dahlberg is a Director at Medistim ASA. Mr. Dahlberg's former jobs include being the Chief Executive Officer of Mole Genetics AS, a Senior Scientist at Orchid Cellmark, Inc., and a Vice President-Sales at Qiagen, Inc. Mr. Dahlberg obtained a graduate degree from the University of Oslo in 1997.
Postes actifs de Ole Dahlberg
| Sociétés | Poste | Début |
|---|---|---|
| MEDISTIM ASA | Directeur/Membre du Conseil | - |
| Qvint Biotech AS | Fondateur | 23/07/2009 |
Nadeno Nanoscience AS
 Nadeno Nanoscience AS BiotechnologyHealth Technology Nadeno Nanoscience AS is a company based in Trondheim, Norway. Nadeno is a Sintef spin-off that specializes in nanotechnology drug delivery platforms. The Norwegian company has developed a platform that focuses on unleashing the potential of hard-to-deliver hydrophobic small molecule drugs. The company's technology is designed to address the majority of failures in drug delivery. The company was founded by Annbjørg Falck and Yrr Mørch, with Annbjørg Falck serving as CEO since incorporation. | Président | 01/02/2023 |
Anciens postes connus de Ole Dahlberg
| Sociétés | Poste | Fin |
|---|---|---|
Cytomics Pharmaceuticals SA
 Cytomics Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Cytomics Pharmaceuticals is a biopharmaceutical company dedicated to discovering and developing drugs that control the degradation of proteins, to treat major human diseases. The company was founded in April 2000 in collaboration with Dominique Thomas (Research Director at the Center for Molecular Genetics of the CNRS) and Richard Benarous (Director of the Department for Infectious Diseases 'at the Cochin Institute of Molecular Genetics), both specialists recognized by the ubiquitin-proteasome protein degradation. | Fondateur | 10/10/2011 |
Qiagen, Inc.
 Qiagen, Inc. Miscellaneous Commercial ServicesCommercial Services Qiagen, Inc. provided technologies for separating, purifying and handling nucleic acids. The company was founded in 1988 and was headquartered in Germantown, MD. | Sales & Marketing | - |
Orchid Cellmark, Inc.
 Orchid Cellmark, Inc. Miscellaneous Commercial ServicesCommercial Services Orchid Cellmark, Inc. provides DNA testing services. It generates genetic profile information by analysing an organism's unique genetic identity. The firm also offers non-DNA forensic laboratory services. The company was founded on March 8, 1995 and is headquartered in Princeton, NJ. | Corporate Officer/Principal | - |
Mole Genetics AS
 Mole Genetics AS BiotechnologyHealth Technology Mole Genetics AS manufactures and sells instruments & pre-filled reagent cartridges for genetic research. The firm product GeneMole is used for automation of DNA and RNA extraction system and MoleStrips is used for prefilled disposable reagent strips. The company was founded by Ole Jesper Dahlberg, Frank Larsen, Arne Deggerdal, and Tone Yrvum in June 2005 and is headquartered in Lysaker, Norway. | President | - |
Formation de Ole Dahlberg
| University of Oslo | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MEDISTIM ASA | Health Technology |
| Entreprise privées | 6 |
|---|---|
Mole Genetics AS
Mole Genetics AS BiotechnologyHealth Technology Mole Genetics AS manufactures and sells instruments & pre-filled reagent cartridges for genetic research. The firm product GeneMole is used for automation of DNA and RNA extraction system and MoleStrips is used for prefilled disposable reagent strips. The company was founded by Ole Jesper Dahlberg, Frank Larsen, Arne Deggerdal, and Tone Yrvum in June 2005 and is headquartered in Lysaker, Norway. | Health Technology |
Cytomics Pharmaceuticals SA
Cytomics Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Cytomics Pharmaceuticals is a biopharmaceutical company dedicated to discovering and developing drugs that control the degradation of proteins, to treat major human diseases. The company was founded in April 2000 in collaboration with Dominique Thomas (Research Director at the Center for Molecular Genetics of the CNRS) and Richard Benarous (Director of the Department for Infectious Diseases 'at the Cochin Institute of Molecular Genetics), both specialists recognized by the ubiquitin-proteasome protein degradation. | Health Technology |
| Qvint Biotech AS | |
Orchid Cellmark, Inc.
Orchid Cellmark, Inc. Miscellaneous Commercial ServicesCommercial Services Orchid Cellmark, Inc. provides DNA testing services. It generates genetic profile information by analysing an organism's unique genetic identity. The firm also offers non-DNA forensic laboratory services. The company was founded on March 8, 1995 and is headquartered in Princeton, NJ. | Commercial Services |
Qiagen, Inc.
Qiagen, Inc. Miscellaneous Commercial ServicesCommercial Services Qiagen, Inc. provided technologies for separating, purifying and handling nucleic acids. The company was founded in 1988 and was headquartered in Germantown, MD. | Commercial Services |
Nadeno Nanoscience AS
Nadeno Nanoscience AS BiotechnologyHealth Technology Nadeno Nanoscience AS is a company based in Trondheim, Norway. Nadeno is a Sintef spin-off that specializes in nanotechnology drug delivery platforms. The Norwegian company has developed a platform that focuses on unleashing the potential of hard-to-deliver hydrophobic small molecule drugs. The company's technology is designed to address the majority of failures in drug delivery. The company was founded by Annbjørg Falck and Yrr Mørch, with Annbjørg Falck serving as CEO since incorporation. | Health Technology |